Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma

被引：11

作者：

Enomoto, M ^{[1
]}

Nishiguchi, S ^{[1
]}

Seki, S ^{[1
]}

Yamane, T ^{[1
]}

Hino, M ^{[1
]}

机构：

[1] Osaka City Univ, Sch Med, Dept Hepatol, Grad Sch Med,Dept Clin Hematol,Abeno Ku, Osaka 5458585, Japan

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 08期

关键词：

D O I：

10.1111/j.1572-0241.2004.40012.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1619 / 1620

页数：2

共 10 条

[1]

Ahmed A, 1999, AM J GASTROENTEROL, V94, P249, DOI 10.1111/j.1572-0241.1999.00808.x

[2] Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].

Angus, P ;

Vaughan, R ;

Xiong, S ;

Yang, HL ;

Delaney, W ;

Gibbs, C ;

Brosgart, C ;

Colledge, D ;

Edwards, R ;

Ayres, A ;

Bartholomeusz, A ;

Locarnini, S .

GASTROENTEROLOGY, 2003, 125 (02) :292-297

[3] Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Calvez, V ;

Fievet, MH ;

Vig, P ;

Gibbs, CS ;

Brosgart, C ;

Fry, J ;

Namini, H ;

Katiama, C ;

Poynard, T .

LANCET, 2001, 358 (9283) :718-723

[4]

Ghany MG, 2000, HEPATOLOGY, V32, p376A, DOI 10.1053/jhep.2000.17912

[5] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Tassopoulos, NC ;

Heathcote, EJ ;

Chang, TT ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807

[6]

Mancuso A, 2002, AM J GASTROENTEROL, V97, P1268

[7] Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B [J].

Marcellin, P ;

Chang, T ;

Lim, SG ;

Tong, MJ ;

Sievert, W ;

Shiffman, ML ;

Jeffers, L ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL ;

Afdhal, N ;

O'Conner, C ;

Andreone, P ;

Cursaro, C ;

Angus, P ;

Vaughan, R ;

Bain, V ;

Gutfreund, K ;

Barange, K ;

Duffant, M ;

Barnes, E ;

Bennett, M ;

Pressman, J ;

Bernstein, D ;

Bonino, F ;

Coco, B ;

Borum, M ;

Schuck, S ;

Bourliere, M ;

Benali, S ;

Boyer, N ;

Castelnau, C ;

Brown, R ;

Scales, S ;

Buggisch, P ;

Peterson, J ;

Cooksley, G ;

MacDonald, G ;

Couzigou, P ;

Foucner, D ;

Crawford, D ;

Der, A ;

Desmond, P ;

Boussioutas, A ;

DiBisceglie, A ;

Bacon, B ;

Dieterich, D ;

Goldman, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :808-816

[8] Combination alpha-interferon and lamivndine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study [J].

Mutimer, D ;

Naoumov, N ;

Honkoop, P ;

Marinos, G ;

Ahmed, M ;

de Man, R ;

McPhillips, P ;

Johnson, M ;

Williams, R ;

Elias, E ;

Schalm, S .

JOURNAL OF HEPATOLOGY, 1998, 28 (06) :923-929

[9]

Ohmoto K, 2003, AM J GASTROENTEROL, V98, P1215

[10] Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B [J].

Tatulli, I ;

Francavilla, R ;

Rizzo, GL ;

Vinciguerra, V ;

Ierardi, E ;

Amoruso, A ;

Panella, C ;

Francavilla, A .

JOURNAL OF HEPATOLOGY, 2001, 35 (06) :805-810

← 1 →